Pulmonary alveolar proteinosis is a rare clinical syndrome that was first described in 1958.
Subsequently, over 240 case reports and small series have described at least 410 cases in …

Pulmonary surfactants consist of phospholipids and the hydrophobic proteins surfactant
protein B and surfactant protein C. These surfactants keep the alveoli in the lung open to the …

Familial pulmonary fibrosis is a heterogeneous group of interstitial lung diseases of
unknown cause that is associated with multiple pathologic subsets. Mutations in the …

34 Rybicki BA, Maliarik MJ, Malvitz E, et al. The influence of T cell receptor and cytokine
genes on sarcoidosis susceptibility in African Americans. Hum Immunol 1999; 60: 867–874 …

We present the clinical, radiologic, and pathologic findings in lung biopsies from seven
infants with atypical neonatal lung disease. All seven infants presented with tachypnea …

Introduction 3. Lessons from the inflammatory pathway 3.1. The paradigm of type 1 or type 2
cytokine network commitment 3.2. Chemokines 3.2. 1. Chemokines in inflammatory/fibrotic …

Ichikado K, Honda O, Mihara N, Kozuka T, et al. Acute respiratory distress syndrome and
acute interstitial pneumonia: comparison of thin-section CT findings. J Comput Assist …

Surfactant protein C (SP-C) is synthesized by type II pneumocytes as a 21-kD propeptide
(proSP-C) which is proteolytically processed to a 4.2-kD dipalmitoylated protein. To …

Pulmonary surfactant is a surface active material composed of both lipids and proteins that is
produced by alveolar type II pneumocytes. Abnormalities of surfactant in the immature lung …

Composition, surface activity and effects on pressure–volume (P–V) mechanics are
examined for lavaged calf lung surfactant (LS) and the clinical exogenous surfactants …